Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Clin Pharmacol Ther ; 19(2): 196-205, 1976 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-770045

RESUMO

A thyroid hormone analogue, sodium dextro-triiodothyronine (NaDT3), at a dosage of 1 mg/day for 1 or 2 yr, decreased serum cholesterol levels about 30% in 26 hyperlipidemic adults. There were less sustained decreases in the serum phospholipids, and occasional lowering of the serum triglycerides, but no effects on body weight, blood pressure, or pulse rate. Changes recognized as variable concomitants of spontaneous or induced thyrotoxicosis, such as transient increases in fasting blood glucose, calcium, and globulin, persistent rises in alkaline phosphatase, and nonsustained decreases in hematocrit are consonant with the fact that Na-DT3 exerts about one tenth of the thyroid hormone activity of LT3. These changes, however, appear to represent actions of iodinated amino acids apart from those effects that result in clinical thyrotoxicosis.


Assuntos
Hipercolesterolemia/tratamento farmacológico , Tri-Iodotironina/uso terapêutico , Adulto , Idoso , Bilirrubina/metabolismo , Contagem de Células Sanguíneas , Glicemia , Nitrogênio da Ureia Sanguínea , Colesterol/sangue , Ensaios Clínicos como Assunto , Enzimas/sangue , Ácidos Graxos não Esterificados/sangue , Humanos , Pessoa de Meia-Idade , Rotação Ocular , Fosfolipídeos/sangue , Placebos , Triglicerídeos/sangue , Tri-Iodotironina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA